USPTO trademark record

ETHIQA XR (BUPRENORPHINE EXTENDED-RELEASE INJECTABLE SUSPENSION) 1.3 MG/ML

Live registered mark · Owner FIDELIS PHARMACEUTICALS LLC · Classes 5

Mark details

Owner: FIDELIS PHARMACEUTICALS LLC
Serial number: 87703113
Registration number: 6158527
Status: SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED
Classes: 5 (Pharmaceuticals)
Filed: 2017-11-30
Registered: 2020-09-22
Goods / services: Pharmaceutical preparations, namely, buprenorphine extended release injectable suspension to provide analgesia for laboratory animals

Register data as of 2026-11-09. Records can trail live filings — check the official USPTO search for the latest status before filing.

Similar marks

Nearest marks in the register to ETHIQA XR (BUPRENORPHINE EXTENDED-RELEASE INJECTABLE SUSPENSION) 1.3 MG/ML.

ETHIQA XRLive

Classes 5 (Pharmaceuticals) · FIDELIS PHARMACEUTICALS LLC

ETHIBOND EXCELLive

Classes 10 (Medical devices) · JOHNSON & JOHNSON

ETHIQLYLive

Classes 42 (Software / tech services (SaaS, design, hosting)) · Pupil, Inc.

ETHIQUELive

Classes 3 (Cosmetics / cleaning), 35 (Advertising / retail / business services) · Ethique Limited

ETHIQUELive

Classes 3 (Cosmetics / cleaning) · Ethique Limited

Screen your own name

A fast first-pass screen against the USPTO federal register — sound-alikes, look-alikes, and same or related classes, in plain English. Free, no signup.

Screen a name — free · Start a free watch